secwatch.observer — SEC 8-K summary
======================================

Issuer:     Merus N.V. (—)
CIK:        0001651311
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001193125-24-172782
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merus appoints Fabian Zohren as CMO with $503K salary; CBO Liu and former CMO Joe depart
--------------------------------------------------------------------------------

- Fabian Zohren named Chief Medical Officer effective July 1, 2024, succeeding Andrew Joe.
- Zohren's base salary $503,000, target bonus 40%, option for 183,943 shares vesting over 4 years.
- Hui Liu (CBO) and Andrew Joe (outgoing CMO) separated same date; severance per agreements.
- Liu receives accelerated vesting of 3,000 RSUs and $17,500 lump sum; option extended to Dec 31, 2024.
- Joe enters 3-month consulting agreement at $41,000/month; option extended to 3 months post-consulting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651311/000119312524172782/0001193125-24-172782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651311/000119312524172782/d862441d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-172782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer